Pfizer's GAAP net income for 6 months of 2023 amounted to $7.894 billion, down 2.3 times from $17.781 billion in the previous year. Revenue fell 41.9% to $31.015 billion against $53.402 billion a year earlier.
Pfizer's GAAP net income for 6 months of 2023 amounted to $7.894 billion, down 2.3 times from $17.781 billion in the previous year. Revenue fell 41.9% to $31.015 billion against $53.402 billion a year earlier. 
English (US) 